2,007
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Nutritional guidelines for the management of insulin resistance

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • Aleixandre, A., and M. Miguel. 2016. Dietary fiber and blood pressure control. Food & Function 7 (4):1864–71. doi: 10.1039/c5fo00950b.
  • Altuntaş, Y. 2019. Postprandial reactive hypoglycemia. SiSli Etfal Hastanesi Tip Bulteni / the Medical Bulletin of Sisli Hospital 53 (3):215–20. doi: 10.14744/SEMB.2019.59455.
  • Armani, A., A. Berry, F. Cirulli, and M. Caprio. 2017. Molecular mechanisms underlying metabolic syndrome: The expanding role of the adipocyte. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 31 (10):4240–55. doi: 10.1096/fj.201601125RRR.
  • Barazzoni, R., G. Cappellari, M. Ragni, and E. Nisoli. 2018. Insulin resistance in obesity: An overview of fundamental alterations. Eating and Weight Disorders: EWD 23 (2):149–57. doi: 10.1007/s40519-018-0481-6.
  • Berry, R., E. Jeffery, and M. S. Rodeheffer. 2014. Weighing in on adipocyte precursors. Cell Metabolism 19 (1):8–20. doi: 10.1016/j.cmet.2013.10.003.
  • Botros, N., I. Rijnaarts, H. Brandts, G. Bleumink, I. Janssen, and H. de Boer. 2014. Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Obesity Surgery 24 (11):1850–5. doi: 10.1007/s11695-014-1319-6.
  • Boucher, J., M. A. Mori, K. Y. Lee, G. Smyth, C. W. Liew, Y. Macotela, M. Rourk, M. Bluher, S. J. Russell, and C. R. Kahn. 2012. Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nature Communications 3:902. doi: 10.1038/ncomms1905.
  • Bozdag, G., S. Mumusoglu, D. Zengin, E. Karabulut, and B. O. Yildiz. 2016. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Human Reproduction (Oxford, England) 31 (12):2841–55. doi: 10.1093/humrep/dew218.
  • Brun, J. F., C. Fedou, and J. Mercier. 2000. Postprandial reactive hypoglycemia. Diabetes & Metabolism 26 (5):337–51.
  • Bull, F. C., S. S. Al-Ansari, S. Biddle, K. Borodulin, M. P. Buman, G. Cardon, C. Carty, J. P. Chaput, S. Chastin, R. Chou, et al. 2020. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. British Journal of Sports Medicine 54 (24):1451–62. doi: 10.1136/bjsports-2020-102955.
  • Cassar, S., M. L. Misso, W. G. Hopkins, C. S. Shaw, H. J. Teede, and N. K. Stepto. 2016. Insulin resistance in polycystic ovary syndrome: A systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Human Reproduction (Oxford, England) 31 (11):2619–31. doi: 10.1093/humrep/dew243.
  • Chakera, A. J., P. S. Hurst, G. Spyer, E. O. Ogunnowo-Bada, W. J. Marsh, C. H. Riches, C. Y. Yueh, S. P. Markkula, J. W. Dalley, R. D. Cox, et al. 2018. Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes. Molecular Metabolism 17:17–27. doi: 10.1016/j.molmet.2018.08.001.
  • Chaudhari, N., M. Dawalbhakta, and L. Nampoothiri. 2018. GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile. Reproductive Biology and Endocrinology: RB&E 16 (1):37. doi: 10.1186/s12958-018-0354-x.
  • Cheatham, B., and C. R. Kahn. 1995. Insulin action and the insulin signaling network. Endocrine Reviews 16 (2):117–42. doi: 10.1210/edrv-16-2-117.
  • Chen, J. P., G. C. Chen, X. P. Wang, L. Qin, and Y. Bai. 2017. Dietary fiber and metabolic syndrome: A meta-analysis and review of related mechanisms. Nutrients 10 (1):24. doi: 10.3390/nu10010024.
  • Cryer, P. E., S. N. Davis, and H. Shamoon. 2003. Hypoglycemia in diabetes. Diabetes Care 26 (6):1902–12. doi: 10.2337/diacare.26.6.1902.
  • Curry, D. L., and J. S. Stern. 1985. Dynamics of insulin hypersecretion by obese Zucker rats. Metabolism 34 (9):791–6. doi: 10.1016/0026-0495(85)90100-3.
  • Davies, M. J., D. A. D'Alessio, J. Fradkin, W. N. Kernan, C. Mathieu, G. Mingrone, P. Rossing, A. Tsapas, D. J. Wexler, and J. B. Buse. 2018. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 41 (12):2669–701. doi: 10.2337/dci18-0033.
  • Di Pino, A., and R. A. De Fronzo. 2019. Insulin resistance and atherosclerosis: Implications for insulin-sensitizing agents. Endocrine Reviews 40 (6):1447–67. doi: 10.1210/er.2018-00141.
  • Diamanti-Kandarakis, E., and A. Dunaif. 2012. Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocrine Reviews 33 (6):981–1030. doi: 10.1210/er.2011-1034.
  • Dunaif, A., J. Xia, C. B. Book, E. Schenker, and Z. Tang. 1995. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. Journal of Clinical Investigation 96 (2):801–10. doi: 10.1172/JCI118126.
  • Dunaif, A., X. Wu, A. Lee, and E. Diamanti-Kandarakis. 2001. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). American Journal of Physiology-Endocrinology and Metabolism 281 (2):E392–E399. doi: 10.1152/ajpendo.2001.281.2.E392.
  • Durning, S. P., H. Flanagan-Steet, N. Prasad, and L. Wells. 2016. O-Linked β-N-acetylglucosamine (O-GlcNAc) acts as a glucose sensor to epigenetically regulate the insulin gene in pancreatic beta cells. The Journal of Biological Chemistry 291 (5):2107–18. doi: 10.1074/jbc.M115.693580.
  • Edelweiss, E., T. G. Balandin, J. L. Ivanova, G. V. Lutsenko, O. G. Leonova, V. I. Popenko, A. M. Sapozhnikov, and S. M. Deyev. 2008. Barnase as a new therapeutic agent triggering apoptosis in human cancer cells. PLoS One 3 (6):e2434. doi: 10.1371/journal.pone.0002434.
  • Elhassan, Y. S., J. Idkowiak, K. Smith, M. Asia, H. Gleeson, R. Webster, W. Arlt, and M. W. O'Reilly. 2018. Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women. The Journal of Clinical Endocrinology and Metabolism 103 (3):1214–23. doi: 10.1210/jc.2017-02426.
  • Esparza-Romero, J., M. E. Valencia, M. E. Martinez, E. Ravussin, L. O. Schulz, and P. H. Bennett. 2010. Differences in insulin resistance in Mexican and U.S. Pima Indians with normal glucose tolerance. The Journal of Clinical Endocrinology and Metabolism 95 (11):E358–E362. doi: 10.1210/jc.2010-0297.
  • Feskens, E. J., S. M. Virtanen, L. Räsänen, J. Tuomilehto, J. Stengård, J. Pekkanen, A. Nissinen, and D. Kromhout. 1995. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 18 (8):1104–12. doi: 10.2337/diacare.18.8.1104.
  • Freeman, J. 2019. Management of hypoglycemia in older adults with type 2 diabetes. Postgraduate Medicine 131 (4):241–50. doi: 10.1080/00325481.2019.1578590.
  • Galati, S. J., and E. J. Rayfield. 2014. Approach to the patient with postprandial hypoglycemia. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20 (4):331–40. doi: 10.4158/EP13132.RA.
  • Gebhard, B., J. J. Holst, C. Biegelmayer, and J. Miholic. 2001. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Digestive Diseases and Sciences 46 (9):1915–23. doi: 10.1023/A:1010635131228.
  • Giacco, R., M. Parillo, A. A. Rivellese, G. Lasorella, A. Giacco, L. D'Episcopo, and G. Riccardi. 2000. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 23 (10):1461–6. doi: 10.2337/diacare.23.10.1461.
  • Glass, C. K., and J. M. Olefsky. 2012. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metabolism 15 (5):635–45. doi: 10.1016/j.cmet.2012.04.001.
  • Gore, A. C., V. A. Chappell, S. E. Fenton, J. A. Flaws, A. Nadal, G. S. Prins, J. Toppari, and R. T. Zoeller. 2015. EDC-2: The Endocrine Society's second scientific statement on endocrine-disrupting chemicals. Endocrine Reviews 36 (6):E1–E150. doi: 10.1210/er.2015-1010.
  • Hall, M., M. Walicka, and I. Traczyk. 2020.Reactive hypoglycemia - an interdisciplinary approach of the disease of XXI Century Wiadomosci lekarskie (Warsaw. Poland: 1960), 73 (2):384–9.
  • Hattersley, J. G., A. F. Pfeiffer, M. Roden, K. J. Petzke, D. Hoffmann, N. N. Rudovich, H. S. Randeva, M. Vatish, M. Osterhoff, Ö. Goegebakan, et al. 2014. Modulation of amino acid metabolic signatures by supplemented isoenergetic diets differing in protein and cereal fiber content. The Journal of Clinical Endocrinology and Metabolism 99 (12):E2599–E2609. doi: 10.1210/jc.2014-2302.
  • Haw, J. S., K. I. Galaviz, A. N. Straus, A. J. Kowalski, M. J. Magee, M. B. Weber, J. Wei, K. M. V. Narayan, and M. K. Ali. 2017. Long-term sustainability of diabetes prevention approaches: A systematic review and meta-analysis of randomized clinical trials. JAMA Internal Medicine 177 (12):1808–17. doi: 10.1001/jamainternmed.2017.6040.
  • Hofeldt, F. D. 1975. Reactive hypoglycemia. Metabolism 24 (10):1193–208. doi: 10.1016/0026-0495(75)90156-0.
  • Højlund, K. 2014. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Danish Medical Journal 61 (7):B4890.
  • Højlund, K., D. Glintborg, N. R. Andersen, J. B. Birk, J. T. Treebak, C. Frøsig, H. Beck-Nielsen, and J. F. Wojtaszewski. 2008. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 57 (2):357–66. doi: 10.2337/db07-0706.
  • Holst, J. J., N. J. Wewer Albrechtsen, J. Pedersen, and F. K. Knop. 2017. Glucagon and amino acids are linked in a mutual feedback cycle: The liver-α-cell axis. Diabetes 66 (2):235–40. doi: 10.2337/db16-0994.
  • Iozzo, P., T. Pratipanawatr, H. Pijl, C. Vogt, V. Kumar, R. Pipek, M. Matsuda, L. J. Mandarino, K. J. Cusi, and R. A. De Fronzo. 2001. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis. American Journal of Physiology-Endocrinology and Metabolism 280 (5):E712–E719. doi: 10.1152/ajpendo.2001.280.5.E712.
  • Jung, C. H., and K. M. Choi. 2017. Impact of high-carbohydrate diet on metabolic parameters in patients with type 2 diabetes. Nutrients 9 (4):322. doi: 10.3390/nu9040322.
  • Kahleova, H., S. Dort, R. Holubkov, and N. D. Barnard. 2018. A plant-based high-carbohydrate, low-fat diet in overweight individuals in a 16-week randomized clinical trial: The role of carbohydrates. Nutrients 10 (9):1302. doi: 10.3390/nu10091302.
  • Kahn, S. E., R. L. Prigeon, D. K. McCulloch, E. J. Boyko, R. N. Bergman, M. W. Schwartz, J. L. Neifing, W. K. Ward, J. C. Beard, and J. P. Palmer. 1993. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42 (11):1663–72. doi: 10.2337/diab.42.11.1663.
  • Kandaswamy, L., R. Raghavan, and J. M. Pappachan. 2016. Spontaneous hypoglycemia: Diagnostic evaluation and management. Endocrine 53 (1):47–57. doi: 10.1007/s12020-016-0902-0.
  • Kandel, D., K. N. Bojsen-Møller, M. S. Svane, A. Samkani, A. Astrup, J. J. Holst, S. Madsbad, and T. Krarup. 2019. Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery. The American Journal of Clinical Nutrition 110 (2):296–304. doi: 10.1093/ajcn/nqy310.
  • Katz, A., S. S. Nambi, K. Mather, A. D. Baron, D. A. Follmann, G. Sullivan, and M. J. Quon. 2000. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. The Journal of Clinical Endocrinology and Metabolism 85 (7):2402–10. doi: 10.1210/jcem.85.7.6661.
  • Kautzky-Willer, A., J. Harreiter, and G. Pacini. 2016. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine Reviews 37 (3):278–316. doi: 10.1210/er.2015-1137.
  • Kempegowda, P., E. Melson, K. N. Manolopoulos, W. Arlt, and M. W. O'Reilly. 2020. Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism 11:2042018820934319. doi: 10.1177/2042018820934319.
  • Kitabchi, A. E., M. Temprosa, W. C. Knowler, S. E. Kahn, S. E. Fowler, S. M. Haffner, R. Andres, C. Saudek, S. L. Edelstein, R. Arakaki, et al. 2005. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: Effects of lifestyle intervention and metformin. Diabetes 54 (8):2404–14. doi: 10.2337/diabetes.54.8.2404.
  • Kittah, N. E., and A. Vella. 2017. Management of endocrine disease: Pathogenesis and management of hypoglycemia. European Journal of Endocrinology 177 (1):R37–R47. doi: 10.1530/EJE-16-1062.
  • Krieger, J. W., H. S. Sitren, M. J. Daniels, and B. Langkamp-Henken. 2006. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: A meta-regression 1. The American Journal of Clinical Nutrition 83 (2):260–74. doi: 10.1093/ajcn/83.2.260.
  • Kulina, G. R., and E. J. Rayfield. 2016. The Role of Glucagon in the pathophysiology and management of diabetes. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 22 (5):612–21. doi: 10.4158/EP15984.RA.
  • Land, G. A., and I. F. Salkin. 1987. Uncommon yeastlike zoopathogens and commercial systems for their identification. Mycopathologia 99 (3):155–71. doi: 10.1007/BF00437438.
  • Lantsberg, L., J. Khodadadi, L. Golcman, Y. Hertzanu, and G. Szendro. 1988. Unusual pseudoaneurysm of Dacron femoro-popliteal graft shaft. A case report. The Journal of Cardiovascular Surgery 29 (3):320–1.
  • Layman, D. K., E. M. Evans, D. Erickson, J. Seyler, J. Weber, D. Bagshaw, A. Griel, T. Psota, and P. Kris-Etherton. 2009. A moderate-protein diet produces sustained weight loss and long-term changes in body composition and blood lipids in obese adults. The Journal of Nutrition 139 (3):514–21. doi: 10.3945/jn.108.099440.
  • Lupoli, R., M. Cotugno, E. Griffo, G. Nosso, G. Riccardi, and B. Capaldo. 2015. Role of the entero-insular axis in the pathogenesis of idiopathic reactive hypoglycemia: A pilot study. The Journal of Clinical Endocrinology & Metabolism 100 (12):4441–6. doi: 10.1210/jc.2015-3309.
  • Lv, X., K. Fang, W. Hao, Y. Han, N. Yang, and Q. Yu. 2020. Identification of reactive hypoglycemia with different basic BMI and its causes by prolonged oral glucose tolerance test. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 13:4717–26. doi: 10.2147/DMSO.S280084.
  • Malin, S. K., E. L. Kullman, A. R. Scelsi, J. M. Haus, J. Filion, M. R. Pagadala, J. P. Godin, S. Kochhar, A. B. Ross, and J. P. Kirwan. 2018. A whole-grain diet reduces peripheral insulin resistance and improves glucose kinetics in obese adults: A randomized-controlled trial. Metabolism 82:111–7. doi: 10.1016/j.metabol.2017.12.011.
  • Martín-Peláez, S., M. Fito, and O. Castaner. 2020. Mediterranean diet effects on type 2 diabetes prevention, disease progression, and related mechanisms. Nutrients 12 (8):2236. doi: 10.3390/nu12082236.
  • Matthews, D. R., J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner. 1985. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (7):412–9. doi: 10.1007/BF00280883.
  • Mayer-Davis, E. J., Jr R. D'Agostino, A. J. Karter, S. M. Haffner, M. J. Rewers, M. Saad, and R. N. Bergman. 1998. Intensity and amount of physical activity in relation to insulin sensitivity: The Insulin Resistance Atherosclerosis Study. JAMA 279 (9):669–74. doi: 10.1001/jama.279.9.669.
  • McAuley, K. A., S. M. Williams, J. I. Mann, A. Goulding, A. Chisholm, N. Wilson, G. Story, R. T. McLay, M. J. Harper, and I. E. Jones. 2002. Intensive lifestyle changes are necessary to improve insulin sensitivity: A randomized controlled trial. Diabetes Care 25 (3):445–52. doi: 10.2337/diacare.25.3.445.
  • McClenaghan, N. H. 2005. Determining the relationship between dietary carbohydrate intake and insulin resistance. Nutrition Research Reviews 18 (2):222–40. doi: 10.1079/NRR2005109.
  • McNabney, S. M., and T. M. Henagan. 2017. Short chain fatty acids in the colon and peripheral tissues: A focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients 9 (12):1348. doi: 10.3390/nu9121348.
  • Mehran, A. E., N. M. Templeman, G. S. Brigidi, G. E. Lim, K. Y. Chu, X. Hu, J. D. Botezelli, A. Asadi, B. G. Hoffman, T. J. Kieffer, et al. 2012. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metabolism 16 (6):723–37. doi: 10.1016/j.cmet.2012.10.019.
  • Moran, L. J., H. Ko, M. Misso, K. Marsh, M. Noakes, M. Talbot, M. Frearson, M. Thondan, N. Stepto, and H. J. Teede. 2013. Dietary composition in the treatment of polycystic ovary syndrome: A systematic review to inform evidence-based guidelines. Journal of the Academy of Nutrition and Dietetics 113 (4):520–45. doi: 10.1016/j.jand.2012.11.018.
  • Morimoto, N., C. Kasuga, A. Tanaka, K. Kamachi, M. Ai, K. Y. Urayama, and A. Tanaka. 2018. Association between dietary fibre: Carbohydrate intake ratio and insulin resistance in Japanese adults without type 2 diabetes. British Journal of Nutrition 119 (6):620–8. doi: 10.1017/S0007114517003725.
  • Nguyen, Q., S. Pandya, K. Chin, and C. G. Parkin. 2018. Use of continuous glucose monitoring in detecting reactive hypoglycemia in individuals without diabetes. Journal of Diabetes Science and Technology 12 (6):1244–5. doi: 10.1177/1932296818777273.
  • Nielsen, T. S., N. Jessen, J. O. Jørgensen, N. Møller, and S. Lund. 2014. Dissecting adipose tissue lipolysis: Molecular regulation and implications for metabolic disease. Journal of Molecular Endocrinology 52 (3):R199–R222. doi: 10.1530/JME-13-0277.
  • Page, M. M., and J. D. Johnson. 2018. Mild suppression of hyperinsulinemia to treat obesity and insulin resistance. Trends in Endocrinology and Metabolism: TEM 29 (6):389–99. doi: 10.1016/j.tem.2018.03.018.
  • Paschou, S. A., P. Anagnostis, and D. G. Goulis. 2018. Weight loss for the prevention and treatment of type 2 diabetes. Maturitas 108:A1–A2. doi: 10.1016/j.maturitas.2017.09.010.
  • Pateguana, N. B., and A. Janes. 2019. The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome. Journal of Insulin Resistance 4 (1):a50. doi: 10.4102/jir.v4i1.50.
  • Patel, S. 2018. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. The Journal of Steroid Biochemistry and Molecular Biology 182:27–36. doi: 10.1016/j.jsbmb.2018.04.008.
  • Pearson, G., F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman, and M. H. Cobb. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocrine Reviews 22 (2):153–83. doi: 10.1210/edrv.22.2.0428.
  • Pérez-Jiménez, F., J. López-Miranda, M. D. Pinillos, E. Paz-Rojas, P. Montilla, C. Marín, M. J. Velasco, A. Blanco-Molina, J. A. Jiménez Perepérez, P. Ordovás, et al. 2001. A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia 44 (11):2038–43. PMID: 11719836. doi: 10.1007/s001250100009.
  • Puddu, A., R. Sanguineti, F. Montecucco, and G. L. Viviani. 2014. Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes. Mediators of Inflammation 2014:1–9. doi:10.1155/2014/162021.
  • Rabe, K., M. Lehrke, K. G. Parhofer, and U. C. Broedl. 2008. Adipokines and insulin resistance. Molecular Medicine (Cambridge, Mass.) 14 (11-12):741–51. doi: 10.2119/2008-00058.Rabe.
  • Roland, A. V., C. S. Nunemaker, S. R. Keller, and S. M. Moenter. 2010. Prenatal androgen exposure programs metabolic dysfunction in female mice. The Journal of Endocrinology 207 (2):213–23. doi: 10.1677/JOE-10-0217.
  • Sacks, F. M., V. J. Carey, C. A. Anderson, E. R. Miller, T. Copeland, J. Charleston, B. J. Harshfield, N. Laranjo, P. McCarron, J. Swain, et al. 2014. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: The OmniCarb randomized clinical trial. JAMA 312 (23):2531–41. doi: 10.1001/jama.2014.16658.
  • Schwingshackl, L., and G. Hoffmann. 2013. Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: A systematic review and meta-analysis. Nutrition Journal 12:48. doi: 10.1186/1475-2891-12-48.
  • Sears, B., and M. Perry. 2015. The role of fatty acids in insulin resistance. Lipids in Health and Disease 14:121. doi: 10.1186/s12944-015-0123-1.
  • Shafaeizadeh, S., L. Muhardi, C. J. Henry, B. van de Heijning, and E. M. van der Beek. 2018. Macronutrient composition and food form affect glucose and insulin responses in humans. Nutrients 10 (2):188. doi: 10.3390/nu10020188.
  • Shanik, M. H., Y. Xu, J. Skrha, R. Dankner, Y. Zick, and J. Roth. 2008. Insulin resistance and hyperinsulinemia: Is hyperinsulinemia the cart or the horse? Diabetes Care 31 (Supplement 2):S262–S268. doi: 10.2337/dc08-s264.
  • Sheng, Z., J.-Y. Cao, Y.-C. Pang, H.-C. Xu, J.-W. Chen, J.-H. Yuan, R. Wang, C.-S. Zhang, L.-X. Wang, and J. Dong. 2019. Effects of lifestyle modification and anti-diabetic medicine on prediabetes progress: A systematic review and meta-analysis. Frontiers in Endocrinology 10:455. doi: 10.3389/fendo.2019.00455.
  • Silbert, R., A. Salcido-Montenegro, R. Rodriguez-Gutierrez, A. Katabi, and R. G. McCoy. 2018. Hypoglycemia among patients with type 2 diabetes: Epidemiology, risk factors, and prevention strategies. Current Diabetes Reports 18 (8):53. doi: 10.1007/s11892-018-1018-0.
  • Sluijs, I., Beulens, J. W. A. D. L. van der, A. M. Spijkerman, D. E. Grobbee, and Y. T. van der Schouw. 2010. Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL study. Diabetes Care 33 (1):43–8. doi: 10.2337/dc09-1321.
  • Smith, U. 2015. Abdominal obesity: A marker of ectopic fat accumulation. The Journal of Clinical Investigation 125 (5):1790–2. doi: 10.1172/JCI81507.
  • Soare, A., Y. M. Khazrai, L. Fontana, R. Del Toro, M. C. Lazzaro, C. D. Rosa, A. Buldo, E. Fioriti, E. Maddaloni, S. Angeletti, et al. 2017. Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial. Metabolism 69:148–56. doi: 10.1016/j.metabol.2017.01.023.
  • Soare, A., E. P. Weiss, and P. Pozzilli. 2014. Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk. Diabetes/Metabolism Research and Reviews 30 Suppl 1:41–7. doi: 10.1002/dmrr.2517.
  • Solomon, T. P., J. M. Haus, K. R. Kelly, M. D. Cook, J. Filion, M. Rocco, S. R. Kashyap, R. M. Watanabe, H. Barkoukis, and J. P. Kirwan. 2010. A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. The American Journal of Clinical Nutrition 92 (6):1359–68. doi: 10.3945/ajcn.2010.29771.
  • Solter, M., and M. Sekso. 1979. Glucose-insulin interaction in obese individuals with asymptomatic reactive hypoglycemia. Acta Diabetologica Latina 16 (2):119–27. doi: 10.1007/BF02581091.
  • Taylor, R. 2012. Insulin resistance and type 2 diabetes. Diabetes 61 (4):778–9. doi: 10.2337/db12-0073.
  • Tomasz, A. 1986. Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics. Reviews of Infectious Diseases 8 Suppl 3 (Suppl 3):S260–S278. doi: 10.1093/clinids/8.supplement_3.s260.
  • Tosi, F., E. Bonora, and P. Moghetti. 2017. Insulin resistance in a large cohort of women with polycystic ovary syndrome: A comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Human Reproduction (Oxford, England) 32 (12):2515–21. doi: 10.1093/humrep/dex308.
  • Tsatsoulis, A., and S. A. Paschou. 2020. Metabolically healthy obesity: Criteria, epidemiology, controversies, and consequences. Current Obesity Reports 9 (2):109–20. doi: 10.1007/s13679-020-00375-0.
  • Tucker, L. A. 2018. Fiber intake and insulin resistance in 6374 Adults: The role of abdominal obesity. Nutrients 10 (2):237. doi: 10.3390/nu10020237.
  • van Nielen, M., E. J. Feskens, A. Rietman, E. Siebelink, and M. Mensink. 2014. Partly replacing meat protein with soy protein alters insulin resistance and blood lipids in postmenopausal women with abdominal obesity. The Journal of Nutrition 144 (9):1423–9. doi: 10.3945/jn.114.193706.
  • van Vliet, S., H. E. Koh, B. W. Patterson, M. Yoshino, R. La Forest, R. J. Gropler, S. Klein, and B. Mittendorfer. 2020. Obesity is associated with increased basal and postprandial β-Cell insulin secretion even in the absence of insulin resistance. Diabetes 69 (10):2112–9. doi: 10.2337/db20-0377.
  • Visuthranukul, C., P. Sirimongkol, A. Prachansuwan, C. Pruksananonda, and S. Chomtho. 2015. Low-glycemic index diet may improve insulin sensitivity in obese children. Pediatric Research 78 (5):567–73. doi: 10.1038/pr.2015.142.
  • Weickert, M. O. 2012. What dietary modification best improves insulin sensitivity and why? Clinical Endocrinology 77 (4):508–12. doi: 10.1111/j.1365-2265.2012.04450.x.
  • Weickert, M. O. 2018. High fiber intake, dietary protein, and prevention of type 2 diabetes. Expert Review of Endocrinology & Metabolism 13 (5):223–4. doi: 10.1080/17446651.2018.1513320.
  • Weickert, M. O., J. G. Hattersley, I. Kyrou, A. M. Arafat, N. Rudovich, M. Roden, P. Nowotny, C. von Loeffelholz, S. Matysik, G. Schmitz, et al. 2018. Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance. Nutrition & Diabetes 8 (1):11. doi: 10.1038/s41387-018-0020-6.
  • Weickert, M. O., and A. Pfeiffer. 2018. Impact of dietary fiber consumption on insulin resistance and the prevention of type 2 diabetes. The Journal of Nutrition 148 (1):7–12. doi: 10.1093/jn/nxx008.
  • Westman, E., W. Yancy, J. Mavropoulos, M. Marquart, and J. McDuffie. 2008. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutrition & Metabolism 5 (1):36. doi: 10.1186/1743-7075-5-36.
  • Wood, R. J., and M. L. Fernandez. 2009. Carbohydrate-restricted versus low-glycemic-index diets for the treatment of insulin resistance and metabolic syndrome. Nutrition Reviews 67 (3):179–83. doi: 10.1111/j.1753-4887.2009.00186.x.
  • Wycherley, T. P., L. J. Moran, P. M. Clifton, M. Noakes, and G. D. Brinkworth. 2012. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: A meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 96 (6):1281–98. doi: 10.3945/ajcn.112.044321.
  • Yazıcı, D., and H. Sezer. 2017. Insulin resistance, obesity and lipotoxicity. Advances in Experimental Medicine and Biology 960:277–304. doi: 10.1007/978-3-319-48382-5_12.
  • Yu, Z., F. Nan, L. Y. Wang, H. Jiang, W. Chen, and Y. Jiang. 2020. Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition 39 (6):1724–34. doi: 10.1016/j.clnu.2019.08.008.
  • Zhao, L., F. Zhang, X. Ding, G. Wu, Y. Y. Lam, X. Wang, H. Fu, X. Xue, C. Lu, J. Ma, et al. 2018. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science (New York, N.Y.) 359 (6380):1151–6. doi: 10.1126/science.aao5774.
  • Zimonjic, D. B., M. E. Durkin, C. L. Keck-Waggoner, S. W. Park, S. S. Thorgeirsson, and N. C. Popescu. 2003. SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma. Neoplasia 5 (5):390–6. (03)80041-6 doi: 10.1016/S1476-5586(03)80041-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.